While the conventional delivery of the CD73 inhibitor (AB680) did not show an effect, delivery of the drug with nanocarrier (F127ZIF‐8AB680) indeed significantly reduced the LLC tumor growth (Figure 8b,c). Here, NT5E is linked to neoplasm.